SLAMF7-directed Immunostimulatory Antibody
- Name
- SLAMF7-directed Immunostimulatory Antibody
- Accession Number
- DBCAT003470
- Description
Not Available
- Drugs
Drug Drug Description Elotuzumab An antineoplastic agent and SLAMF7-directed immunostimulatory antibody used for the treatment of refractory multiple myeloma in combination with other antineoplastic agents. - Drugs & Drug Targets
Drug Target Type Elotuzumab SLAM family member 7 target